Literature DB >> 10234868

Effects of a psychosocial intervention on survival among patients with stage I breast and prostate cancer: a matched case-control study.

D Shrock1, R F Palmer, B Taylor.   

Abstract

CONTEXT: Psychosocial factors have been linked to the development and progression of cancer and shown to be relevant in cancer care. However, the evidence that psychosocial interventions affect cancer survival is less conclusive. Few methodologically sound studies have addressed this issue.
OBJECTIVE: To investigate the effects of a 6-week psychosocial intervention on survival among patients with stage I breast and prostate cancer.
DESIGN: Matched case-control.
SETTING: 3 rural hospitals or cancer centers in central Pennsylvania. PATIENTS: 21 breast and 29 prostate stage I cancer patients (treatment group) matched with 74 breast and 65 prostate stage I cancer patients from the same hospitals who did not receive the intervention (control group). INTERVENTION: Six 2-hour health psychology classes conducted by a licensed staff psychologist. MAIN OUTCOME MEASURES: Survival time was compared between the 2 groups and with national norms.
RESULTS: The intervention group lived significantly longer than did matched controls. At 4- to 7-year follow-up (median = 4.2 years), none of the breast cancer patients in the intervention group died, whereas 12% of those in the control group died. Twice as many matched-control prostate cancer patients died compared with those in the intervention group (28% vs 14%). Control group survival was similar to national norms.
CONCLUSIONS: These results are consistent with prior clinical trials and suggest that short-term psychosocial interventions that encourage the expression of emotions, provide social support, and teach coping skills can influence survival among cancer patients. However, self-selection bias cannot be ruled out as an alternative explanation for the results. These interventions merit further consideration and research.

Entities:  

Mesh:

Year:  1999        PMID: 10234868

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  8 in total

Review 1.  Biobehavioral outcomes following psychological interventions for cancer patients.

Authors:  Barbara L Andersen
Journal:  J Consult Clin Psychol       Date:  2002-06

2.  Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials.

Authors:  Kevin Lee Du; Kyounghwa Bae; Benjamin Movsas; Yan Yan; Charlene Bryan; Deborah Watkins Bruner
Journal:  Support Care Cancer       Date:  2011-07-01       Impact factor: 3.603

Review 3.  Coping with prostate cancer: a meta-analytic review.

Authors:  Scott C Roesch; Linda Adams; Amanda Hines; Alan Palmores; Pearlin Vyas; Cindy Tran; Shannon Pekin; Allison A Vaughn
Journal:  J Behav Med       Date:  2005-06

4.  Quality of life after breast cancer diagnosis and survival.

Authors:  Meira Epplein; Ying Zheng; Wei Zheng; Zhi Chen; Kai Gu; David Penson; Wei Lu; Xiao-Ou Shu
Journal:  J Clin Oncol       Date:  2010-12-20       Impact factor: 44.544

Review 5.  What is the state of the evidence on the mind-cancer survival question, and where do we go from here? A point of view.

Authors:  Joanne E Stephen; Michelle Rahn; Marja Verhoef; Anne Leis
Journal:  Support Care Cancer       Date:  2007-06-26       Impact factor: 3.603

6.  The effect of psychosocial factors on breast cancer outcome: a systematic review.

Authors:  Matthew E Falagas; Effie A Zarkadoulia; Eleni N Ioannidou; George Peppas; Christos Christodoulou; Petros I Rafailidis
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

Review 7.  Targeted drugs and Psycho-oncological intervention for breast cancer patients.

Authors:  Flavio D'Abramo; Ute Goerling; Cecilia Guastadisegni
Journal:  J Negat Results Biomed       Date:  2016-04-01

8.  The utility of a multimedia education program for prostate cancer patients: a formative evaluation.

Authors:  D Flynn; P van Schaik; A van Wersch; T Ahmed; D Chadwick
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.